We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Dermatologic toxicities of anti-neoplastic immunotherapy in United States hospitalizations

    A major side effect of anti-neoplastic immunotherapy is the onset of dermatologic toxicities following the administration of several different...

    Shrey Patel, Shiv Patel, ... Vinod E. Nambudiri in Archives of Dermatological Research
    Article 12 April 2023
  2. Identification of potential oral cancer drugs as Bcl-2 inhibitors from known anti-neoplastic agents through docking studies

    Oral Cancer is one of the major killers in India and of global concern. An attempt has been made here to identify small molecule inhibitors of Bcl-2...

    Chandan Raychaudhury, Shreyaa Srinivasan, Debnath Pal in Journal of Mathematical Chemistry
    Article 13 November 2023
  3. Development of a claims-based risk-scoring model to predict emergency department visits in older patients receiving anti-neoplastic therapy

    This study developed and validated a risk-scoring model, with a particular emphasis on medication-related factors, to predict emergency department...

    Yewon Suh, Jonghyun Jeong, ... Ju-Yeun Lee in Scientific Reports
    Article Open access 17 January 2024
  4. Anti-coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions

    Low molecular weight heparins (LMWH) and anti-Xa direct oral anti-coagulants (DOACs) are recommended for the long-term treatment of cancer-associated...

    Claire Grange, Catherine Rioufol, ... Souad Assaad in Clinical Pharmacokinetics
    Article Open access 12 October 2023
  5. Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer

    The main focus of our study is to assess the anti-cancer activity of cimetidine and vitamin C via combating the tumor supportive role of mast cell...

    Sherihan Salaheldin Abdelhamid Ibrahim, Sarah A. Abd El-Aal, ... Yasmine Shahine in Scientific Reports
    Article Open access 07 July 2022
  6. Anti-neoplastic pharmacophore benzophenone-1 coumarin (BP-1C) targets JAK2 to induce apoptosis in lung cancer

    Reigning of the abnormal gene activation associated with survival signalling in lung cancer leads to the anomalous growth and therapeutic failure....

    Ankith Sherapura, Vikas H. Malojirao, ... B. T. Prabhakar in Apoptosis
    Article 27 November 2021
  7. Psoriasis in the Era of Targeted Cancer Therapeutics: A Systematic Review on De Novo and Pre-existing Psoriasis in Oncologic Patients Treated with Emerging Anti-neoplastic Agents

    New advancements in medicine have paved the way for targeted therapies and immune checkpoint inhibitors (ICIs), which have become mainstays of cancer...

    Vrinda Madan, Laura I. Ortiz-López, ... Vinod E. Nambudiri in Dermatology and Therapy
    Article Open access 22 June 2024
  8. Association of inappropriate polypharmacy with emergency department visits in older patients receiving anti-neoplastic therapy: a population-based study

    Purpose

    We aimed to investigate the prevalence and predicting factors of inappropriate polypharmacy including potentially inappropriate medications...

    Yewon Suh, Young-Mi Ah, ... Ju-Yeun Lee in Supportive Care in Cancer
    Article 10 October 2020
  9. Drug Repurposing for Treatment of Cancer

    Drug repurposing is a ray of hope for therapy of various diseases including cancer. Since historical times, drugs like nitrogen mustards,...
    Reference work entry 2024
  10. Anti-neoplastic Immunomodulatory Treatments and the Pituitary

    Immune checkpoint inhibitors (CPIs) have transformed the landscape of oncology since the approval of ipilimumab by the US Food and Drug...
    Michelle Rengarajan, Alexander Faje in Pituitary Disorders throughout the Life Cycle
    Chapter 2022
  11. Drug Solubilization and Drug Release from Polymeric Micelles

    Amphiphilic polymeric block copolymers find frequent applications due to their ability to deliver hydrophobic moieties to the physiological system....
    Ganesh Vambhurkar, Naitik Jain, ... Saurabh Srivastava in Polymeric Micelles: Principles, Perspectives and Practices
    Chapter 2023
  12. Nanotechnology in Drug Delivery

    A biologically active substance (chemical compound, peptide, antibodies, gene-based drugs etc.) capable of producing a therapeutic effect can be...
    Mayuri Napagoda, Sanjeeva Witharana in Nanotechnology in Modern Medicine
    Chapter 2023
  13. Adverse Drug Reactions

    Adverse events and adverse drug reactions are common in clinical practice. Side effects range from the common to the rare and may be confused with...
    Chapter 2023
  14. Cancer drug sensitivity prediction from routine histology images

    Drug sensitivity prediction models can aid in personalising cancer therapy, biomarker discovery, and drug design. Such models require survival data...

    Muhammad Dawood, Quoc Dang Vu, ... Fayyaz ul Amir Afsar Minhas in npj Precision Oncology
    Article Open access 06 January 2024
  15. Drug Repurposing for Treatment of Cancer

    Drug repurposing is a ray of hope for therapy of various diseases including cancer. Since historical times, drugs like nitrogen mustards,...
    Living reference work entry 2023
  16. Drug Repurposing for Hematological Malignancies

    Hematological malignancies are cancer that affects blood, bone marrow, and lymph nodes. They are classified as leukemia, lymphoma, and myeloma based...
    Antony Anista Michael, Pavithra Balakrishnan, Thirunavukkarasu Velusamy in Drug Repurposing for Emerging Infectious Diseases and Cancer
    Chapter 2023
  17. Cancer Drug Resistance and Metabolic Reprogramming

    There is a complex and strong association between metabolic reprogramming and the phenomenon of drug resistance in cancer. Cancer cell metabolic...
    Shariqa Jan, Kaneez Fatima, ... Sameer Ullah Khan in Drug Resistance in Cancer: Mechanisms and Strategies
    Chapter 2024
  18. Cell–drug conjugates

    By combining living cells with therapeutics, cell–drug conjugates can potentiate the functions of both components, particularly for applications in...

    Yanfang Wang, Jiaqi Shi, ... Zhen Gu in Nature Biomedical Engineering
    Article 01 July 2024
  19. Prevalence and factors associated with potential drug-drug interactions in prescriptions presented at private pharmacies in Mbarara city, southwestern Uganda

    Background

    Drug-drug interactions (DDIs) influence the effectiveness of medication and thus determine the treatment outcomes of diseases managed with...

    Allan Phillip Lule, Ogwal Basil Delic, ... Tadele Mekuriya Yadesa in BMC Pharmacology and Toxicology
    Article Open access 02 January 2024
  20. Fabrication of folic acid-embedded aminated drug encapsulated zeolitic imidazolate framework as promising drug delivery system for lung cancer

    A novel pH-responsive drug carrier for the delivery of specific Docetaxel (DTX) administration is developed based on a zeolitic imidazolate framework...

    Arunachalam Chinnathambi, Sulaiman Ali Alharbi, ... Sridhar Muthusami in Journal of Materials Research
    Article 05 April 2024
Did you find what you were looking for? Share feedback.